CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes

• Sabrina Kneissl ,

  Contributed equally to this work with: Sabrina Kneissl, Qi Zhou

  Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany

  ⨯
• Qi Zhou ,

  Contributed equally to this work with: Sabrina Kneissl, Qi Zhou

  Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany

  ⨯
• Michael Schwenkert,

  Current address: AbD Serotec, A Bio-Rad Company, Puchheim, Germany

  Affiliation Department of Biology, University of Erlangen-Nuremberg, Erlangen, Germany

  ⨯
• François-Loic Cosset,

  Affiliation CIRI, International Center for Infectiology Research, EVIR team, Inserm U1111, CNRS, UMR5308, Université de Lyon-1, ENS de Lyon, Lyon, France

  ⨯
• Els Verhoeyen,

  Affiliations CIRI, International Center for Infectiology Research, EVIR team, Inserm U1111, CNRS, UMR5308, Université de Lyon-1, ENS de Lyon, Lyon, France, INSERM, U895, Centre de Médecine Moléculaire (C3M), équipe 3, Nice, France

  ⨯
• Christian J. Buchholz

  * E-mail: Christian.Buchholz@pei.de

  Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany

  ⨯